Definium Therapeutics, Inc. (DFTX) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$6,016
Total Return
-39.84%
CAGR
-9.66%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.45% |
| Median | -1.69% |
| Best | +129.31% |
| Worst | -73.02% |
| % of Windows Positive | 46.5% |
1-Year (252 Trading Days)
| Average | +20.49% |
| Median | +8.03% |
| Best | +340.29% |
| Worst | -94.24% |
| % of Windows Positive | 52.2% |
3-Year (756 Trading Days)
| Average | +62.72% |
| Median | -51.16% |
| Best | +672.57% |
| Worst | -87.85% |
| % of Windows Positive | 30.3% |
Risk Metrics
| Maximum Drawdown | -96.96% |
| Average Drawdown | -81.25% |
| Drawdown Duration | 1246 Trading Days (Unrecovered) |
| Sortino Ratio | 0.53 |
| Calmar Ratio | -0.10 |
| CVaR (5%) | -10.35% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +63.78% (+465.56% ann.) | +$6377.89 | $0.00 | $0.00 | $0.00 |
| 2025 | +92.39% | +$9238.51 | $0.00 | $0.00 | $0.00 |
| 2024 | +90.16% | +$9016.39 | $0.00 | $0.00 | $0.00 |
| 2023 | +66.36% | +$6636.36 | $0.00 | $0.00 | $0.00 |
| 2022 | -89.37% | $8937.20 | $0.00 | $0.00 | $0.00 |
| 2021 | -54.75% | $5475.41 | $0.00 | $0.00 | $0.00 |
| 2020 | +5346.43% | +$534642.68 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +16.67% (+129744729.17% ann.) | +$1666.67 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | December 27, 2019 – February 19, 2020 | +4.17% | +31.80% | +$416.67 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | +304.00% | +834204962.90% | +$30399.98 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +310.31% | +869.44% | +$31031.39 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +106.50% | +98.96% | +$10649.89 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -91.89% | -93.05% | $9188.55 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +133.08% | +57.86% | +$13307.69 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +260.69% | +126.54% | +$26069.08 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.